Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Galmed Pharmaceuticals Ltd
NASDAQ:GLMD

Watchlist Manager
Galmed Pharmaceuticals Ltd Logo
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
Watchlist
Price: 0.67 USD 0.69% Market Closed
Market Cap: $3.7m
Write Note Create Alert Ask AI

Galmed Pharmaceuticals Ltd
Investor Relations

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Show more
Loading
GLMD
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2021
Call Date
May 2, 2022
Q4 2021 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Open Transcript
Other Earnings Calls

Management

Mr. Allen Baharaff
Co-Founder, President, CEO & Chairman
No Bio Available
Mr. Doron Cohen
Chief Financial Officer
No Bio Available
Mr. Guy Nehemya
COO & Data Protection Officer
No Bio Available
Mr. Yohai Stenzler CPA
Chief Accounting Officer
No Bio Available
Dr. Liat Hayardeny MBA, Ph.D.
Chief Scientific Officer
No Bio Available
Dr. Tali Gorfine
Medical Consultant
No Bio Available

Contacts

Address
TEL AVIV-YAFO
16 Ze'ev Tyomkin St. (4Th Fl.)
Contacts
+97236938448.0
www.galmedpharma.com
sparklesyt

See Also

Summary
GLMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
GLMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GLMD stock valuation using valuation multiples.
Wall Street Estimates
GLMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GLMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.